Clinical trial
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or…
NCT00324597 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00324597 |
|---|---|
| Title | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma |
| Official title | A Phase Ib, Open-Label, Sequential, Dose-Finding, Study of AMG 706 in Combination With Gemcitabine to Treat Subjects With Solid Tumors |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | gemcitabine hydrochloride, motesanib diphosphate, pharmacological study |
| Enrollment | 18 |
| Start date | Oct 1, 2005 |
| First posted | May 11, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: